Watson-Marlow Fluid Technology Group (WMFTG), a specialist in niche peristaltic pumps and associated fluid path technologies, has acquired Asepco through its parent company Spirax-Sarco Engineering for GBP 7M. Asepco, based in California USA, specialises in the design and manufacture of high purity aseptic valves and magnetic mixers for the bioprocessing industry.
Asepco is a natural extension of the WMFTG fluid path product portfolio and further strengthens the company’s strong global presence in the biotechnology and pharmaceutical industries. Asepco joins a product range comprising Watson-Marlow Pumps, Watson-Marlow Tubing, Flexicon Filling Systems, BioPure single-use tubing connector systems, Alitea OEM Pumps, MasoSine Process Pumps and Bredel Hose Pumps.
There is clear synergy and a significant growth opportunity presented by bringing together Asepco’s product range and WMFTG’s products to meet the needs of the biopharmaceutical market. Asepco complements WMFTG’s range by utilising patented technology to improve sterility levels within the biotechnology production process. This improved process sterility reduces the risks surrounding validation in demanding contamination-free applications.
Jay Whalen, president of the Watson-Marlow Fluid Technology Group comments: “The strategic acquisition of Asepco further broadens our product range and strengthens Watson-Marlow’s position in the biopharmaceutical market. This is another exciting milestone for Watson-Marlow and we are looking forward to accelerating our growth within the biopharmaceutical market with our broadened product portfolio coupled to our process expertise”.